CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 55 filers reported holding CIDARA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $254,000,000 | -25.9% | 20,000 | 0.0% | 0.01% | -16.7% |
Q4 2015 | $343,000,000 | -18.5% | 20,000 | -39.6% | 0.01% | -33.3% |
Q3 2015 | $421,000,000 | -9.3% | 33,112 | 0.0% | 0.01% | +12.5% |
Q2 2015 | $464,000,000 | – | 33,112 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,627,670 | $1,533,591 | 1.88% |
5AM Venture Management, LLC | 1,134,511 | $1,068,936 | 0.31% |
Nantahala Capital Management | 2,538,406 | $2,391,686 | 0.20% |
BVF INC/IL | 6,861,127 | $6,464,554 | 0.17% |
Monashee Investment Management LLC | 369,099 | $347,765 | 0.14% |
West Family Investments, Inc. | 368,910 | $347,587 | 0.12% |
JEPPSON WEALTH MANAGEMENT, LLC | 137,560 | $129,609 | 0.06% |
XTX Topco Ltd | 202,758 | $191,039 | 0.03% |
GSA CAPITAL PARTNERS LLP | 136,974 | $129 | 0.01% |
Callan Capital, LLC | 103,462 | $97,482 | 0.01% |